M, P., D, H., C, K., N, K., N, T., CS, Z., . . . EM, K. (2020). Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease. Journal of clinical immunology, 40(4), 619. https://doi.org/10.1007/s10875-020-00772-z
Chicago Style (17th ed.) CitationM, Parta, Hilligoss D, Kelly C, Kwatemaa N, Theobald N, Zerbe CS, Holland SM, Malech HL, and Kang EM. "Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease." Journal of Clinical Immunology 40, no. 4 (2020): 619. https://doi.org/10.1007/s10875-020-00772-z.
MLA (9th ed.) CitationM, Parta, et al. "Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease." Journal of Clinical Immunology, vol. 40, no. 4, 2020, p. 619, https://doi.org/10.1007/s10875-020-00772-z.